Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation: Genomics & Proteomics
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.4 Assumptions And Stipulations
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Genomics and Proteomics Market
Chapter 3 Global Genomics and Proteomics Market Overview
3.1 Genomics and Proteomics Industry Overview and Milestones
3.2 Applications of Genomics and Proteomics Technologies
3.2.1 Agriculture and Animal Husbandry
3.2.2 Drug Discovery
3.2.3 Forensics
3.2.4 Proteogenomics Research
3.2.5 Disease Identification, Diagnostics and Control
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Drug Discovery and Disease Identification a Strong Driver
3.3.1.2 Increased Investment in Healthcare and Medical Research by Developing Countries
3.3.1.3 Software and Service Sector in Genomics and Proteomics is Booming
3.3.2 Restraints
3.3.2.1 Low Adoption and Penetration in Developing Countries due to Cost of Technology
3.3.2.2 Highly Fragmented Market may Increase Volume but is Expected to Reduce in Terms of Revenue
3.3.3 Opportunities
3.3.3.1 Collaboration for Research with Research Facilities in Developing Countries
3.4 Market Attractiveness for Genomics and Proteomics Market, by Geography
3.5 Porters Five Forces Analysis for Genomics and Proteomics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from Substitutes
3.5.4 Threat from New Entrants
3.5.5 Degree of Competitive Rivalry
Chapter 4 Global Genomics and Proteomics Reagents and Research Kits Market
4.1 Sample Preparation Kits Market
4.1.1 Global Sample Preparation Kits Market, By Segments, 2011 - 2019 (USD Million)
4.1.2 Prepackaged Sample Preparation for Polymerase Chain Reaction
4.1.3 Prepackaged Sample Preparation for Mass Spectrometry
4.1.4 Prepackaged Sample Preparation for Chromatography
4.1.5 Prepackaged Sample Preparation for Electrophoresis
4.2 Purification Reagent Kits
4.2.1 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
4.2.2 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3 Electrophoresis Kits
4.3.1 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3.2 Capillary Electrophoresis
4.3.3 Gel Electrophoresis
4.4 Biochips and Microarrays
4.4.1 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
4.4.2 DNA Microarrays
4.4.3 Protein and Peptide Microarrays
Chapter 5 Global Genomics and Proteomics Analytical Tools Market, by Technologies, 2011 - 2019 (USD Million)
5.1 Chromatography
5.1.1 Global Chromatography Market, by Types, 2011 - 2019 (USD Million)
5.1.2 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
5.1.3 Gas Chromatography
5.1.4 Liquid Chromatography
5.1.4.1 High Performance Liquid Chromatography
5.1.4.2 Ultra High Performance Chromatography
5.2 Mass Spectrometry
5.2.1 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
5.2.2 Tandem Mass Spectrometry
5.2.3 Quadrupole Mass Spectrometry
5.2.4 Fourier Transform Mass Spectrometry
5.2.5 TOF Mass Spectrometry
5.2.6 Other Mass Spectrometry Analyzers
5.3 Thermal Cyclers
5.3.1 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
5.3.2 Digital PCR Thermal Cyclers
5.3.3 Conventional or Traditional Thermal Cyclers
5.3.4 Real-Time PCR Thermal Cyclers
5.4 Next Generation Sequencing
5.4.1 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)
Chapter 6 Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.1 Introduction
6.1.1 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.2 North America
6.2.1 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.5 Rest of the World
6.5.1 Row Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
Chapter 7 Market Share Analysis of Key Players, 2012
7.1 Market Share Analysis of Key Players, 2012 (%)
Chapter 8 Company Profiles
8.1 Affymetrix
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Becton Dickinson & Company
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Bio-Rad
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Bruker Corporation
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Danaher Corporation
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.7 Illumina, Inc.
8.7.1 Business Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Business Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Merck Millipore
8.9.1 Business Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Myriad Genetics, Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Perkinelmer
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Qiagen
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
8.13 Shimadzu Biotech
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Sigma Aldrich Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Thermo Fisher Scientific
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
List of Tables
TABLE 1 Market Snapshot: Global Genomics and Proteomics Market
TABLE 2 Global Sample Preparation Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 3 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 4 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 5 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 6 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
TABLE 7 Global Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 8 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
TABLE 9 Global Liquid Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 10 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
TABLE 11 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
TABLE 12 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)
TABLE 13 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
TABLE 14 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 15 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 16 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 17 ROW Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
List of Figures
FIG. 1 Genomics & Proteomics Market Segmentation
FIG. 2 Global Genomics and Proteomics Market, by Segments, 2012 (USD Million)
FIG. 3 Market Attractiveness for Genomics and Proteomics Market, by Geography
FIG. 4 Porter’s Five Forces Analysis for Genomics and Proteomics Market
FIG. 5 Global Sample Preparation Kits Market for PCR, 2011-2019 (USD Million)
FIG. 6 Global Sample Preparation Kits Market for Mass Spectrometry, 2011-2019 (USD Million)
FIG. 7 Global Sample Preparation Kits Market for Chromatography, 2011-2019 (USD Million)
FIG. 8 Global Sample Preparation Kits Market for Electrophoresis, 2011-2019 (USD Million)
FIG. 9 Global Capillary Electrophoresis Market, 2011-2019 (USD Million)
FIG. 10 Global Gel Electrophoresis Market, 2011-2019 (USD Million)
FIG. 11 Global DNA Microarrays Market, 2011-2019 (USD Million)
FIG. 12 Global Protein and Peptide Microarrays Market, 2011-2019 (USD Million)
FIG. 13 Global Gas Chromatography Market, 2011-2019 (USD Million)
FIG. 14 Global Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 15 Global High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 16 Global Ultra High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 17 Global Tandem Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 18 Global Quadrupole Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 19 Global Fourier Transform Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 20 Global Time-Of-Flight Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 21 Global Other Mass Spectrometers Market, 2011-2019 (USD Million)
FIG. 22 Global Digital Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 23 Global Conventional or Traditional Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 24 Global Real-Time Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 25 Global Next Generation Sequencers Market, 2011-2019 (USD Million)
FIG. 26 North America Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 27 Europe Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 28 Asia-Pacific Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 29 Rest of the World Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 30 Global Genomics and Proteomics Market Share Analysis of Key Players, 2012 (%)
FIG. 31 Affymetrix: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 32 Agilent Technologies: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 33 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 34 Bio-Rad: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 35 Bruker Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 36 Danaher Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 37 Illumina, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 38 Life Technologies Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 39 Merck Millipore: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 40 Myriad Genetics, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 41 Perkinelmer: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 42 Qiagen: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 43 Shimadzu Biotech: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 44 Sigma Aldrich: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 45 Thermo Scientific Fisher: Annual Sales Revenue, USD Million, 2010 – 2012